PLUS THERAPEUTICS, INC. — Director's Dealing 2015

May 14, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2015-05-08

Reporting Person: Hawkins Richard J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-05-08	Restricted Stock Award (Common Stock)	A	34228	—	Acquired	34228	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	41926	Direct

Footnotes

F1: This Restricted Stock Award ("Award") was granted to the board members in lieu of cash fees payable pursuant to the Director Compensation Plan. The Award vests in full on December 31, 2015, subject to continued service as a Director.

F2: The present Form 4 was not filed within 2 business days of the transaction date.